Yale Jen
Stock Analyst at Laidlaw & Co.
(0)
# 5094
Out of 5,218 analysts
18
Total ratings
10.00%
Success rate
-50.39%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Abivax | Initiates Coverage On: Buy | 48 | 7.15 | 571.33% | 1 | Jul 29, 2024 | |
MEI Pharma | Downgrades: Hold | n/a | n/a | n/a | 1 | Jul 23, 2024 | |
Affimed | Maintains: Buy | 15 25 | 2.13 | 1073.71% | 1 | Jun 13, 2024 | |
BiomX | Initiates Coverage On: Buy | 25 | 0.63 | 3868.25% | 1 | May 28, 2024 | |
IN8bio | Initiates Coverage On: Buy | 8 | 0.29 | 2486.21% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 0.83 | 1104.82% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 240 | 1.93 | 12335.23% | 1 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 0.19 | 15689.47% | 1 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 32 | n/a | n/a | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Dec 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 720 | n/a | n/a | 1 | Sep 19, 2017 |